No interactions in humans have been described. Combining<unk>  with an ACE inhibitor can theoretically increase the risk for angioedema.<unk>  and its main metabolites neither inhibit nor induce the liver enzymes CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A4. They also do not induce UGT enzymes. This means that<unk>  has a low potential for pharmacokinetic interactions.
Racecadotril
Moexipril
Spirapril
Ramipril
Macitentan
Methallenestril
Ambrisentan
Oprelvekin